Vmbook Online ordering

Icons

I'm happy to help with your request!

Icon plc is a public company that is listed on the NASDAQ stock exchange in the United States, with the ticker symbol "ICLR". Icon is a global provider of drug development solutions and services, including outsourced pharmaceutical development, clinical trial management, and commercialization services.

In terms of financial performance, Icon has generally delivered solid earnings and growth over the past several years. Here are some key financial metrics for Icon:

- Revenue: Icon's revenue has grown steadily over the past five years, with revenue of $4.2 billion in 2020, up from $3.2 billion in 2016.

- Earnings per share (EPS): Icon's EPS has also grown steadily over the past five years, with EPS of $5.51 in 2020, up from $3.15 in 2016.

- Dividends: Icon has a strong track record of paying dividends to shareholders, with an annual dividend yield of around 1%.

- Market capitalization: As of March 2023, Icon has a market capitalization of around $26 billion.

It's important to note that past performance is not necessarily indicative of future results, and investors should always do their own research and due diligence when evaluating a potential investment. In addition, investors should be aware of potential risks and uncertainties, such as changes in regulatory policies, economic conditions, and industry trends, that could impact Icon's financial performance going forward.